Adial Pharmaceuticals, Inc. Other Noncash Income (Expense)
Adial Pharmaceuticals, Inc. (ADIL) reported Other Noncash Income (Expense) of $75.32 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2022-11-14
- Adial Pharmaceuticals, Inc. other noncash income (expense) for the quarter ending 2022-09-30 was -$4.89K.
- Adial Pharmaceuticals, Inc. other noncash income (expense) for the quarter ending 2022-06-30 was $4.21K.
- Adial Pharmaceuticals, Inc. other noncash income (expense) for the quarter ending 2022-03-31 was $75.99K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month |
|---|---|---|---|
| 2022-09-30 | -$4.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$672.00 derived: sum of 2 quarters · filed 2022-11-14 | $75.32K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $80.21K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $75.99K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |